Calcium-Independent PLA2Beta in Beta-Cell Apoptosis

Beta 细胞凋亡中的钙依赖性 PLA2Beta

基本信息

  • 批准号:
    7467301
  • 负责人:
  • 金额:
    $ 28.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-09-30 至 2010-04-09
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Endoplasmic reticulum (ER) stress leads to beta-cell apoptosis that is suppressed by inhibition of the Group VIA Ca2+-independent phospholipase A2 (iPLA2beta), and our hypothesis is that iPLA2beta participates in ER stress-induced beta-cell apoptosis. In both type 1 and type 2 diabetes mellitus (DM), beta-cell apoptosis contributes to the loss of beta-cells and decreases in beta-cell function. It is therefore important to understand the mechanisms underlying beta-cell apoptosis if this process is to be prevented or delayed. The secretory nature of beta-cells endows them with a highly developed ER making them susceptible to ER stress. This process is suggested to promote beta-cell apoptosis and, in part, contribute to the decreases in beta-cell mass and beta-cell dysfunction in T2DM. The iPLA2beta catalyzes hydrolysis of arachidonic acid from membrane phospholipids and has a signal transduction role in beta-cells. We observed that ER stress-induced beta-cell apoptosis is related to the levels of iPLA2beta expression, is associated with perinuclear accumulation of a caspase-3-cleaved iPLA2beta isoform and increased generation of arachidonic acid and ceramides, and is suppressed by iPLA2beta inhibition. ER stress-induced apoptosis of pancreatic islets is also attenuated by inactivation of iPLA2beta and iPLA2beta -KO islets are less susceptible to ER stress. We propose to further examine the role of iPLA2a in a-cell apoptosis using pancreatic islets (wild type and iPLA2beta -KO) and INS-1 cells (parental, iPLA2beta over expressing, and iPLA2beta -KO) through the following Aims: Aim 1 is to characterize participation of iPLA2beta in beta-cell apoptosis using stimuli that induce both a-cell apoptosis and ER stress. Aim 2 is to examine the roles and subcellular localization of iPLA2beta isoforms in beta-cell apoptosis by expressing truncated and mutated iPLA2beta isoforms in a-cells. Aim 3 is to identify beta-cell subcellular phospholipid substrates for iPLA2beta during ER stress using ESI/MS/MS protocols. Aim 4 is to examine involvement of iPLA2beta phosphorylation and iPLA2beta -derived arachidonic acid in beta-cell apoptosis using LC/ESI/MS/MS and biochemical analyses.
描述(由申请人提供):内质网(ER)应激导致β细胞凋亡,通过抑制VIA组钙离子非依赖性磷脂酶A2(iPLA 2 β)抑制β细胞凋亡,我们的假设是iPLA 2 β参与ER应激诱导的β细胞凋亡。在1型和2型糖尿病(DM)中,β细胞凋亡导致β细胞损失和β细胞功能降低。因此,重要的是要了解β细胞凋亡的机制,如果这个过程是要预防或延迟。β细胞的分泌性质赋予它们高度发达的ER,使它们对ER应激敏感。这一过程被认为促进β细胞凋亡,并在一定程度上导致T2 DM中β细胞质量和β细胞功能障碍的减少。iPLA 2 β催化花生四烯酸从膜磷脂中水解,并在β细胞中具有信号转导作用。我们观察到ER应激诱导的β细胞凋亡与iPLA 2 β表达水平相关,与caspase-3切割的iPLA 2 β亚型的核周积累以及花生四烯酸和神经酰胺的产生增加相关,并被iPLA 2 β抑制剂抑制。ER应激诱导的胰岛细胞凋亡也通过iPLA 2 β和iPLA 2 β的失活而减弱-KO胰岛对ER应激较不敏感。我们建议通过以下目的使用胰岛(野生型和iPLA 2 β-KO)和INS-1细胞(亲本、iPLA 2 β过表达和iPLA 2 β-KO)进一步检查iPLA 2 α在α-细胞凋亡中的作用:目的1是使用诱导α-细胞凋亡和ER应激的刺激物表征iPLA 2 β参与β-细胞凋亡。目的2是通过在α细胞中表达截短和突变的iPLA 2 β亚型来检查iPLA 2 β亚型在β细胞凋亡中的作用和亚细胞定位。目的3是使用ESI/MS/MS方案鉴定ER应激期间iPLA 2 β的β细胞亚细胞磷脂底物。目的4是使用LC/ESI/MS/MS和生物化学分析来检查iPLA 2 β磷酸化和iPLA 2 β衍生的花生四烯酸在β细胞凋亡中的参与。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SASANKA RAMANADHAM其他文献

SASANKA RAMANADHAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SASANKA RAMANADHAM', 18)}}的其他基金

Exploiting iPLA2β-modified macrophages as immunotherapy for T1D
利用 iPLA2β 修饰巨噬细胞作为 T1D 的免疫疗法
  • 批准号:
    10431074
  • 财政年份:
    2022
  • 资助金额:
    $ 28.15万
  • 项目类别:
Exploiting iPLA2β-modified macrophages as immunotherapy for T1D
利用 iPLA2β 修饰巨噬细胞作为 T1D 的免疫疗法
  • 批准号:
    10620299
  • 财政年份:
    2022
  • 资助金额:
    $ 28.15万
  • 项目类别:
Importance of immune-cell lipid signaling in events leading to type 1 diabetes
免疫细胞脂质信号传导在导致 1 型糖尿病的事件中的重要性
  • 批准号:
    9807734
  • 财政年份:
    2019
  • 资助金额:
    $ 28.15万
  • 项目类别:
Contribution of β-Cell- & Immune Cell-Derived Lipids to β-Cell Death and Diabetes
β-Cell的贡献-
  • 批准号:
    9315157
  • 财政年份:
    2016
  • 资助金额:
    $ 28.15万
  • 项目类别:
Contribution of β-Cell- & Immune Cell-Derived Lipids to β-Cell Death and Diabetes
β-Cell的贡献-
  • 批准号:
    9159460
  • 财政年份:
    2016
  • 资助金额:
    $ 28.15万
  • 项目类别:
HIV-PROTEASE INHIBITORS SUPPRESS SKELETAL MUSCLE FATTY ACID OXIDATION
HIV 蛋白酶抑制剂抑制骨骼肌脂肪酸氧化
  • 批准号:
    8361453
  • 财政年份:
    2011
  • 资助金额:
    $ 28.15万
  • 项目类别:
AGE-RELATED CHANGES IN BONE MORPHOLOGY ARE ACCELERATED IN GROUP VIA
VIA 组中与年龄相关的骨形态变化加速
  • 批准号:
    8168762
  • 财政年份:
    2010
  • 资助金额:
    $ 28.15万
  • 项目类别:
AGE-RELATED CHANGES IN BONE MORPHOLOGY ARE ACCELERATED IN GROUP VIA
VIA 组中与年龄相关的骨形态变化加速
  • 批准号:
    7954015
  • 财政年份:
    2009
  • 资助金额:
    $ 28.15万
  • 项目类别:
ISLET COMPLEX LIPID IN GROUP VIA CALCIUM INDEPENDENT PHOSPHOLIPASE A2 IN B CELL
B 细胞中通过钙独立磷脂酶 A2 组中的胰岛复合脂质
  • 批准号:
    7355207
  • 财政年份:
    2006
  • 资助金额:
    $ 28.15万
  • 项目类别:
GROUP VIA PHOSPHOLIPASE A2 IN ENDOPLASMIC RETICULUM STRESS INDUCED APOPTOSIS
内质网应激诱导的细胞凋亡中通过磷脂酶 A2 进行的组
  • 批准号:
    7355180
  • 财政年份:
    2006
  • 资助金额:
    $ 28.15万
  • 项目类别:

相似海外基金

Mechanisms that underlie the life/death decisions in a cell that activated apoptotic caspases
细胞中激活凋亡半胱天冬酶的生/死决策的机制
  • 批准号:
    10607815
  • 财政年份:
    2023
  • 资助金额:
    $ 28.15万
  • 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
  • 批准号:
    10723868
  • 财政年份:
    2023
  • 资助金额:
    $ 28.15万
  • 项目类别:
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
  • 批准号:
    10862033
  • 财政年份:
    2023
  • 资助金额:
    $ 28.15万
  • 项目类别:
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
凋亡供体白细胞促进肾移植耐受
  • 批准号:
    10622209
  • 财政年份:
    2023
  • 资助金额:
    $ 28.15万
  • 项目类别:
Design of apoptotic cell mimetic anti-inflammatory polymers for the treatment of cytokine storm
用于治疗细胞因子风暴的模拟凋亡细胞抗炎聚合物的设计
  • 批准号:
    22H03963
  • 财政年份:
    2022
  • 资助金额:
    $ 28.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1
确定线粒体基质定位的 MCL-1 非凋亡功能背后的机制
  • 批准号:
    10537709
  • 财政年份:
    2022
  • 资助金额:
    $ 28.15万
  • 项目类别:
Activation of non-apoptotic cell death by the DNA damage response
DNA 损伤反应激活非凋亡细胞死亡
  • 批准号:
    10388929
  • 财政年份:
    2022
  • 资助金额:
    $ 28.15万
  • 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
  • 批准号:
    10356565
  • 财政年份:
    2022
  • 资助金额:
    $ 28.15万
  • 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
  • 批准号:
    10708827
  • 财政年份:
    2022
  • 资助金额:
    $ 28.15万
  • 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
  • 批准号:
    10538071
  • 财政年份:
    2022
  • 资助金额:
    $ 28.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了